Indian Air Force Pharmaceutical and Medical Supply Procurement

Work Description - NA

The Department of Military Affairs, under the Ministry of Defence, represented by the Indian Air Force, is issuing Tender GEM/2026/B/7826466, commencing on August 18, 2026, at 09:55 AM and concluding on August 29, 2026, at 10:00 AM. This tender, dated August 18, 2026, pertains to the procurement of a diverse range of pharmaceuticals, including but not limited to Capecitabine 500 mg tablets, Doxorubicin HCl Injection 2mg/ml (25 ml), Paclitaxel 100mg Injection, Pemetrexed 500 mg powder for injection, Eplerenone 25 mg tablets, Pancreatic Enzyme supplements with a lipase content of 25,000 units or more capsules, Papaverine Hydrochloride 50 mg/2 ml Injection, Fluticasone Furoate Umeclidinium and Vilanterol (100 mcg/62.5 mcg/25 mcg) Multi-Dose Dry Powder Inhaler (30 doses), Atorvastatin 40 Mg tablets, Efavirenz 600mg tablets, and Acalabrutinib 100 mg capsules, as well as Natalizumab 300 mg/15 ml injection. The total quantity required for these items is 58,644 units. Applications are to be submitted to the designated authority within the Indian Air Force, located in Bangalore.